|
| |
| | | 69000 | | 21.07.2023 | | Mepha Pharma AG | | | | | | | 20.07.2028 | | | | | | | | | | 15.01. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Sugammadex-Mepha 200 mg/2 ml | Injektionslösung | Injection solution (Sugammadexum 200mg / 2ml) | V03AB35 | | | 02 | Sugammadex-Mepha 500 mg/5 ml | Injektionslösung | Injection solution (Sugammadexum 500mg / 5ml) | V03AB35 | |
|
|
|
